Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem/Stromal Cells
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Cell Culture Media & Supplements
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Exosomes/Extracellular Vesicles
      • Media & Supplements
      • cGMP CliniControl™ Production Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor Screening Kits
      • hMSC Tissue Screening Kits
      • Bioreactor Kits & Bundles
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem/Stromal Cells
      • Cell Culture Media & Supplements
      • Exosome/Extracellular Vesicle Production Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Press Releases

Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes

January 5, 2023

FUJIFILM Diosynth Biotechnologies & RoosterBio Announce Collaboration to Enable GMP Manufacturing of Cell & Exosome Therapies

October 25, 2022

2022 Development Award Winners

September 22, 2022

RoosterBio & MBL Beijing Biotech Partner to Accelerate Advanced Therapy Manufacturing in China

August 30, 2022

RoosterBio & AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell & Exosome Therapies

August 16, 2022

ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases & Cancer

April 26, 2022

Univercells Technologies Partners with RoosterBio to Advance Scalable & Continuous Exosomes Manufacture

January 20, 2022

RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer

October 5, 2021

RoosterBio Releases RoosterGEM™, Cell & Gene Therapy’s First Complete Transduction Medium

May 20, 2021

RoosterBio Announces Winners of 2020 hMSC Development Grants

March 11, 2021
1 2 3 4 5 6 7 Next

Sidebar Navigation

  • News
  • Events
  • Press Releases
  • Media Kit

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem/Stromal Cells
    • Cell Culture Media & Supplements
    • Exosomes/Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2023 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email